Maze Therapeutics
$31.48
14
-$0.45-1.41%Friday 20:00
-$0.89-2.83%Friday 23:30After hours
Statistics
Day High
31.51
Day Low
31.43
52W High
53.65
52W Low
21.95
Volume
25,202
Avg. Volume
-
Mkt Cap
1.75B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 5Expected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.15
-0.92
-0.68
-0.45
Expected EPS
-0.759389
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-131.12MNet Income
Analyst Ratings
$65.80Average Price Target
The highest estimate is 110.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MAZE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
Show More
CEO
Jason Coloma
Employees
141
Country
United States
ISIN
US5787841007
Listings
0 Comments
Share your thoughts
FAQs
What is Maze Therapeutics stock price today?▼
The current price of MAZE is $31.48 USD — it has decreased by -1.41% in the past 24 hours. Watch Maze Therapeutics stock price performance more closely on the chart.
What is Maze Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Maze Therapeutics stocks are traded under the ticker MAZE.
Is Maze Therapeutics stock price growing?▼
MAZE stock has risen by +1.32% compared to the previous week, the month change is a +19.11% rise, over the last year Maze Therapeutics has showed a -4.35% decrease.
What is Maze Therapeutics market cap?▼
Today Maze Therapeutics has the market capitalization of 1.75B
When is the next Maze Therapeutics earnings date?▼
Maze Therapeutics is going to release the next earnings report on November 5, 2026.
What were Maze Therapeutics earnings last quarter?▼
MAZE earnings for the last quarter are -0.76 USD per share, whereas the estimation was -0.72 USD resulting in a -5.95% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Maze Therapeutics revenue for the last year?▼
Maze Therapeutics revenue for the last year amounts to 0 USD.
What is Maze Therapeutics net income for the last year?▼
MAZE net income for the last year is -131.12M USD.
How many employees does Maze Therapeutics have?▼
As of November 2, 2026, the company has 141 employees.
In which sector is Maze Therapeutics located?▼
Maze Therapeutics operates in the Health & Wellness sector.
When did Maze Therapeutics complete a stock split?▼
Maze Therapeutics has not had any recent stock splits.
Where is Maze Therapeutics headquartered?▼
Maze Therapeutics is headquartered in SOUTH SAN FRANCISCO, United States.